Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...

Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, ...

Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

There are currently two approved drugs in the oral SERD class, namely Menarini/Stemline's Orserdu (elacestrant) and Eli Lilly ...

Mineralocorticoid receptor antagonist (MRA) Kerendia (finerenone) – one of Bayer's top growth prospects – is already approved ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

Jiangsu Hengrui Pharma's oral thrombopoietin (TPO) receptor agonist hetrombopag has been approved in China to treat low ...

At present, the only FDA-approved oral therapies for HAE are BioCryst's Orladeyo (berotralstat) and KalVista Pharma's Ekterly ...